Perceptive Advisors LLC

Perceptive Advisors LLC

Perceptive Advisors LLC

Overview
Date Founded

1999

Headquarters

51 Astor Place, 10th floor, New York, NY, 10003, United States

Type of Company

Private

Employees (Worldwide)

27

Industries

Hedge Funds
Investment Services & Portfolio Management

Company Description

Founded in 1999, Perceptive Advisors focuses on supporting progress in the life sciences industry by identifying opportunities and directing financial resources toward the most promising technologies in modern healthcare. Today, the firm manages approximately $7.3 billion across our strategies.

Contact Data
Trying to get in touch with decision makers at Perceptive Advisors LLC? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Financial Officer

Chief Investment Officer

Chief Operating Officer

Chief Compliance Officer

Chief Credit Officer

Chief Financial Officer, Credit & Venture

Managing Director, Regulatory

Managing Director, Strategy

Managing Director

Paths to Perceptive Advisors LLC
Potential Connections via
Relationship Science
You
Perceptive Advisors LLC
Recent Transactions
Details Hidden

Alliqua BioMedical, Inc., ALQA Cedar, Inc. purchase Celleration, Inc. from Affinity Capital Management Co., Venture Investors LLC, SightLine Partners LLC, AAVIN Private Equity, Prism Capital Corp., New Science Ventures LLC, Triathlon Medical Venture Partners LLC, Seneca Partners, Inc., CID Capital Ventures, CHV Capital, Inc.

Transaction Clients
Lender

Advised on Alliqua BioMedical, Inc., ALQA Cedar, Inc. purchase Celleration, Inc. from Affinity Capital Management Co., Venture Investors LLC, SightLine Partners LLC, AAVIN Private Equity, Prism Capital Corp., New Science Ventures LLC, Triathlon Medical Venture Partners LLC, Seneca Partners, Inc., CID Capital Ventures, CHV Capital, Inc.

Advisors & Consultants
Administrator

The Bank of New York Mellon Corp. is a bank holding company, which engages in the provision of financial services. It operates through the Investment Services and Investment Management segments. The Investment Services segment includes institutional trust and custody fees, broker-dealer services, corporate trust, depositary receipts, and foreign exchange. The Investment Management segment provides services to institutional and retail investors, as well as investment management, wealth and estate planning. The company was founded by Alexander Hamilton on June 9, 1784 and is headquartered in New York, NY.

Custodian

Morgan Stanley & Co. LLC is an SEC-registered broker/dealer headquartered in New York City and was founded in 1969. The firm is the primary broker subsidiary of Morgan Stanley (NYSE: MS). They are a member of FINRA. Morgan Stanley provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry.

Custodian

Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm is the wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. Founded in 1971, DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. The firm focuses primarily on the consumer, energy, utilities, chemicals, financial institutions, financial sponsors, healthcare, hospitality, leisure, industrials, media, natural resources, real estate, technology and telecommunications sectors.

Investments
Details Hidden

Frequency Therapeutics, Inc. engages in the development of small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Its product pipeline include Sensorineural hearing loss (FX-322), and Multiple Sclerosis. The company was founded by Robert S. Langer, Jr., David L. Lucchino, Christopher Loose and Will J. McLean on November 13, 2014 and is headquartered in Woburn, MA.

Details Hidden

AnaptysBio, Inc. is a clinical stage biotechnology company, which engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. It also offers SHM platform that replicate the natural process of somatic hypermutation embedded within the human immune system to rapidly develop a diverse range of therapeutic-grade antibodies in vitro. The company was founded by Andrew B. Cubitt, William J. Boyle, Kevin J. Kinsella, and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.

Details Hidden

Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Perceptive Advisors LLC. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Perceptive Advisors LLC's profile does not indicate a business or promotional relationship of any kind between RelSci and Perceptive Advisors LLC.